BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/09/2009

FDA Announces Draft Guidance for Surgical Ablation Devices for Atrial Fibrillation Treatment

The FDA has released a draft guidance outlining proposed clinical trial designs for surgical ablation devices aimed at treating atrial fibrillation, a condition affecting the heart's rhythm.

Source: Federal Register — Food and Drug AdministrationOpen original release →